TITLE

DSM & Taiyo Unveil Teavigo EGCG Licensing Agreement

PUB. DATE
September 2014
SOURCE
Nutraceuticals World;Sep2014, Vol. 17 Issue 7, p21
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the licensing agreement established by nutritional product supplier Koninklijke DSM NV and functional ingredients manufacturer Taiyo Kagaku Co. Ltd. for DSM's Teavigo brand EGCG business.
ACCESSION #
97669290

 

Related Articles

  • CRUCELL/DSM SIGN LICENSING PACT WITH MITSUBISHI PHARMA.  // Worldwide Biotech;May2005, Vol. 17 Issue 5, p3 

    Reports on a PER. C6 cell line research license agreement signed by DSM Biologics with Japanese pharmaceutical company Mitsubishi Pharma Corp. in 2005. Benefit of the license agreement for Mitsubishi; Terms of the contract; Information on DSM Biologics.

  • MorphoSys Signs Cooperative Agreements.  // Pharmaceutical Technology;Oct2006, Vol. 30 Issue 10, p166 

    The article announces the license agreement signed by MorphoSys AG with Crucell NV and DSM Biologics. The agreement allows the former to use a cell line designed to produce clinical-grade material and develop its therapeutic human antibody program. The financial details of these agreements were...

  • DSM Biologics and Crucell Enter Licensing Deal. Bryner, Michelle // Chemical Week;8/1/2007, Vol. 169 Issue 26, p19 

    The article reports that DSM Biologics and Crucell of Leiden, the Netherlands have entered into an agreement to license a manufacturing technology based on the companies' jointly developed PER.C6 cell line, to LFB Biotechnologies of Paris, France. LFB will use the licensed technology to develop...

  • Pharmaceuticals & fine chemicals.  // Chemical Week;1/1/2003, Vol. 165 Issue 1, p33 

    Presents news briefs on the chemical industry as of January 1, 2003. License deal signed by DSM Biologics with Crucell; Acquisition of the patents of Novozymes relating to the production of a recombinant enzyme for pharmaceutical applications by Solvay.

  • Collaborations: DSM Biologics and Crucell Announce Licensing Deal with LFB Biotechnologies.  // Pharmaceutical Technology;Sep2007, Vol. 31 Issue 9, p134 

    The article reports that DSM Biologics of New Jersey and the biotechnology company Crucell NV of the Netherlands has signed a nonexclusive research licensing agreement with LFB Biotechnologies of Paris, France. It is stated that the LFB will use the PER.C6 production technology of Crucell to...

  • Crucell signs licensing deal. Tyler, Alan // European Chemical News;6/14/2004, Vol. 80 Issue 2104, p29 

    Reports on the research licensing deal signed by Dutch biotechnology player Crucell with PanGenetics. Significance of the deal to PanGenetics; Payment and annual maintenance fees to be received by Crucell and DSM Biologics; Description made by PanGenetics on itself.

  • Taiyo Kagaku.  // Dairy Foods;Jan2003, Vol. 104 Issue 1, p32 

    Focuses on the role of the Taiyo Kagaku company as a dairy industry supplier. Company profile; Products offered.

  • Groundbreaking Iron Fortifier SunActive Fe: Best New Product.  // Alive: Canada's Natural Health & Wellness Magazine;Jul2003, Issue 249, p78 

    Reports on Taiyo's development of a ferric pyrophosphate compound for use in foods, beverages and supplements, which received the NutrAward for the Best New Product, at the 2003 Nutracon/Natural Products Expo in Anaheim, California.

  • World Briefs.  // Pharmaceutical Technology;Aug2008, Vol. 32 Issue 8, p22 

    The article offers world news briefs related to pharmaceutical industry. In Asia and Pacific, NovaMed Pharmaceuticals (Shanghai) and Pfizer China has formed a partnership in the oncology area in distributing oncology products throughout mainland China. In Europe, an agreement is made between DSM...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics